Eric H. Raabe

5.0k total citations
87 papers, 1.8k citations indexed

About

Eric H. Raabe is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Eric H. Raabe has authored 87 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 32 papers in Genetics and 28 papers in Cancer Research. Recurrent topics in Eric H. Raabe's work include Glioma Diagnosis and Treatment (32 papers), Chromatin Remodeling and Cancer (20 papers) and Cancer Mechanisms and Therapy (19 papers). Eric H. Raabe is often cited by papers focused on Glioma Diagnosis and Treatment (32 papers), Chromatin Remodeling and Cancer (20 papers) and Cancer Mechanisms and Therapy (19 papers). Eric H. Raabe collaborates with scholars based in United States, Germany and Netherlands. Eric H. Raabe's co-authors include Charles G. Eberhart, Kenneth J. Cohen, Alan K. Meeker, Ulf D. Kahlert, Harpreet Kaur, R.J. Arceci, Jarek Maciaczyk, Marianne Hütt-Cabezas, Allison Martin and Xinggang Mao and has published in prestigious journals such as Genes & Development, PLoS ONE and PEDIATRICS.

In The Last Decade

Eric H. Raabe

80 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric H. Raabe United States 25 1.2k 635 467 372 224 87 1.8k
Abhik Ray‐Chaudhury United States 22 943 0.8× 285 0.4× 557 1.2× 322 0.9× 226 1.0× 55 1.8k
Arend Koch Germany 34 1.4k 1.2× 848 1.3× 421 0.9× 333 0.9× 415 1.9× 85 2.6k
Evelina Miele Italy 25 1.5k 1.2× 528 0.8× 799 1.7× 237 0.6× 426 1.9× 121 2.3k
Bárbara Meléndez Spain 22 859 0.7× 442 0.7× 421 0.9× 228 0.6× 439 2.0× 66 1.6k
Hiroyuki Momota Japan 19 846 0.7× 669 1.1× 357 0.8× 233 0.6× 246 1.1× 39 1.5k
Daniel W. Fults United States 23 1.6k 1.3× 680 1.1× 257 0.6× 250 0.7× 371 1.7× 38 2.1k
Beth Coyle United Kingdom 22 1.1k 1.0× 1.0k 1.6× 378 0.8× 368 1.0× 346 1.5× 59 2.1k
Markus J. Riemenschneider Germany 21 529 0.4× 738 1.2× 329 0.7× 274 0.7× 195 0.9× 59 1.5k
Birgit Meyer‐Puttlitz Germany 16 916 0.8× 628 1.0× 313 0.7× 334 0.9× 191 0.9× 19 1.6k
Karisa C. Schreck United States 16 946 0.8× 505 0.8× 290 0.6× 140 0.4× 418 1.9× 55 1.4k

Countries citing papers authored by Eric H. Raabe

Since Specialization
Citations

This map shows the geographic impact of Eric H. Raabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric H. Raabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric H. Raabe more than expected).

Fields of papers citing papers by Eric H. Raabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric H. Raabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric H. Raabe. The network helps show where Eric H. Raabe may publish in the future.

Co-authorship network of co-authors of Eric H. Raabe

This figure shows the co-authorship network connecting the top 25 collaborators of Eric H. Raabe. A scholar is included among the top collaborators of Eric H. Raabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric H. Raabe. Eric H. Raabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Best, Simon R., Jonathan M. Bock, Eric H. Raabe, et al.. (2024). A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis. The Laryngoscope. 134(12). 5041–5046. 6 indexed citations
3.
Seiwert, Tanguy Y., et al.. (2024). Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience. The Laryngoscope. 134(7). 3253–3259. 5 indexed citations
4.
Raabe, Eric H., et al.. (2024). Approaches for prevention of tumors in patients with rhabdoid tumor predisposition syndrome. Neuro-Oncology Advances. 6(1). vdae158–vdae158. 2 indexed citations
5.
Eberhart, Charles G., et al.. (2023). ATRT-04. TARGETING THE COREST COMPLEX HELPS REPROGRAM AT/RT’S ABNORMAL EPIGENETIC LANDSCAPE TOWARD A DIFFERENTIATION PHENOTYPE. Neuro-Oncology. 25(Supplement_1). i1–i2. 1 indexed citations
6.
Rubens, Jeffrey, Susan Chi, Tom Rosenberg, et al.. (2023). Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor. Neoplasia. 37. 100880–100880. 15 indexed citations
7.
Maxwell, Micah J., Antje Arnold, Lijun Chen, et al.. (2021). Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAFV600E Mutant Glioma. Molecular & Cellular Proteomics. 20. 100123–100123. 5 indexed citations
8.
Katsushima, Keisuke, Bongyong Lee, Cuncong Zhong, et al.. (2020). The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas. Neuro-Oncology. 23(4). 572–585. 26 indexed citations
9.
Raabe, Eric H., et al.. (2020). Non-adhesive and highly stable biodegradable nanoparticles that provide widespread and safe transgene expression in orthotopic brain tumors. Drug Delivery and Translational Research. 10(3). 572–581. 11 indexed citations
10.
Wang, Sabrina, Brad Poore, Jesse Alt, et al.. (2019). Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine. Clinical Cancer Research. 25(19). 5925–5936. 23 indexed citations
11.
Meel, Michaël H., Mark C. de Gooijer, Míriam Guillén Navarro, et al.. (2018). MELK Inhibition in Diffuse Intrinsic Pontine Glioma. Clinical Cancer Research. 24(22). 5645–5657. 32 indexed citations
12.
Tantravedi, Saritha, Farhad Vesuna, Paul T. Winnard, et al.. (2018). Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33. Translational Oncology. 12(1). 96–105. 37 indexed citations
13.
Wagner, Matthias, William R. Bell, Thangamadhan Bosemani, et al.. (2016). Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas. European Journal of Radiology. 85(4). 700–706. 11 indexed citations
14.
Kaur, Harpreet, Marianne Hütt-Cabezas, Isabella Taylor, et al.. (2016). The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer Letters. 377(1). 55–64. 47 indexed citations
15.
Brandt, William D., Karisa C. Schreck, Eli E. Bar, et al.. (2015). Notch Signaling Activation in Pediatric Low-Grade Astrocytoma. Journal of Neuropathology & Experimental Neurology. 74(2). 121–131. 6 indexed citations
16.
Ahsan, Sama, Eric H. Raabe, Michael C. Haffner, et al.. (2014). Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathologica Communications. 2(1). 59–59. 33 indexed citations
17.
Raabe, Eric H., Kah Suan Lim, Julia M. Kim, et al.. (2011). BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model. Clinical Cancer Research. 17(11). 3590–3599. 137 indexed citations
18.
Raabe, Eric H., Mark L. Laudenslager, Cynthia Winter, et al.. (2007). Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene. 27(4). 469–476. 116 indexed citations
19.
Raabe, Eric H., et al.. (2001). An SNF2 factor involved in mammalian development and cellular proliferation. Developmental Dynamics. 221(1). 92–105. 22 indexed citations
20.
Raabe, Eric H., Keiko Yoshida, & Gerald A. Schwarting. (1997). Differential laminin isoform expression in the developing rat olfactory system. Developmental Brain Research. 101(1-2). 187–196. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abhik Ray‐Chaudhury Breakdown of academic impact, for papers by Arend Koch Breakdown of academic impact, for papers by Evelina Miele Breakdown of academic impact, for papers by Bárbara Meléndez Breakdown of academic impact, for papers by Hiroyuki Momota Breakdown of academic impact, for papers by Daniel W. Fults Breakdown of academic impact, for papers by Beth Coyle Breakdown of academic impact, for papers by Markus J. Riemenschneider Breakdown of academic impact, for papers by Birgit Meyer‐Puttlitz Breakdown of academic impact, for papers by Karisa C. Schreck
Rankless by CCL
2026